{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:02:54Z","timestamp":1789560174873,"version":"build-2803163510"},"reference-count":53,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":580,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008081","name":"DebRA International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008081","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jackson Gabriel Silver Fund"},{"DOI":"10.13039\/100002077","name":"Epidermolysis Bullosa Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000885","name":"Children\u2019s Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000885","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"NCRR","doi-asserted-by":"publisher","award":["1 S10 RR16851"],"award-info":[{"award-number":["1 S10 RR16851"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR059947"],"award-info":[{"award-number":["R01 AR059947"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1038\/jid.2013.523","type":"journal-article","created":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T09:44:18Z","timestamp":1386323058000},"page":"1246-1254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["Patient-Specific Naturally Gene-Reverted Induced Pluripotent Stem Cells in Recessive Dystrophic Epidermolysis Bullosa"],"prefix":"10.1016","volume":"134","author":[{"given":"Jakub","family":"Tolar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"McGrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan J.","family":"Riddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Eide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas R.","family":"Keene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Osborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy C.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Blazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2013.523_bb0010","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/nbt.1503","article-title":"Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes","volume":"26","author":"Aasen","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1038\/jid.2013.523_bb0015","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/jid.2010.64","article-title":"Revertant mosaicism in recessive dystrophic epidermolysis bullosa","volume":"130","author":"Almaani","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.523_bb0020","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.stem.2011.03.001","article-title":"Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency","volume":"8","author":"Anokye-Danso","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1038\/jid.2013.523_bb0025","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1182\/blood.V92.2.699","volume":"92","author":"Ariga","year":"1998","journal-title":"Blood"},{"key":"10.1038\/jid.2013.523_bb0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jcp.10260","article-title":"Participation of bone marrow derived cells in cutaneous wound healing","volume":"196","author":"Badiavas","year":"2003","journal-title":"J Cell Physiol"},{"key":"10.1038\/jid.2013.523_bb0035","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/jid.2010.364","article-title":"Differentiation of mouse induced pluripotent stem cells into a multipotent keratinocyte lineage","volume":"131","author":"Bilousova","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.523_bb0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.det.2009.10.020","article-title":"Dystrophic epidermolysis bullosa: pathogenesis and clinical features","volume":"28","author":"Bruckner-Tuderman","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1038\/jid.2013.523_bb0045","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nmeth.1593","article-title":"Chemically defined conditions for human iPSC derivation and culture","volume":"8","author":"Chen","year":"2011","journal-title":"Nat Methods"},{"key":"10.1038\/jid.2013.523_bb0050","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2353\/ajpath.2008.070977","article-title":"Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance","volume":"173","author":"Chino","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1038\/jid.2013.523_bb0055","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nprot.2010.184","article-title":"Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells","volume":"6","author":"Choi","year":"2011","journal-title":"Nat Protoc"},{"key":"10.1038\/jid.2013.523_bb0060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/14653241003587637","article-title":"Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa","volume":"12","author":"Conget","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1038\/jid.2013.523_bb0065","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1172\/JCI4338","article-title":"Revertant mosaicism: partial correction of a germ-line mutation in COL17A1 by a frame-restoring mutation","volume":"103","author":"Darling","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2013.523_bb0070","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2133.2009.09243.x","article-title":"Gene therapy of inherited skin adhesion disorders: a critical overview","volume":"161","author":"De Luca","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2013.523_bb0075","first-page":"1019","article-title":"Somatic intragenic recombination within the mutated locus BLM can correct the high sister-chromatid exchange phenotype of Bloom syndrome cells","volume":"57","author":"Ellis","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1038\/jid.2013.523_bb0080","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1749-6632.2010.05463.x","article-title":"Inherited epidermolysis bullosa: past, present, and future","volume":"1194","author":"Fine","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1038\/jid.2013.523_bb0085","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jaad.2008.02.004","article-title":"The classification of inherited epidermolysis bullosa (EB): Report of the Third International Consensus Meeting on Diagnosis and Classification of EB","volume":"58","author":"Fine","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2013.523_bb0090","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1091\/mbc.e07-01-0029","article-title":"Epigenetic reprogramming of OCT4 and NANOG regulatory regions by embryonal carcinoma cell extract","volume":"18","author":"Freberg","year":"2007","journal-title":"Mol Biol Cell"},{"key":"10.1038\/jid.2013.523_bb0095","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1172\/JCI34292","article-title":"A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy","volume":"118","author":"Fritsch","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2013.523_bb0100","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.arr.2009.02.002","article-title":"Can hematopoietic stem cells be an alternative source for skin regeneration?","volume":"8","author":"Fu","year":"2009","journal-title":"Ageing Res Rev"},{"key":"10.1038\/jid.2013.523_bb0105","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1073\/pnas.051609898","article-title":"Somatic mosaicism in Fanconi anemia: evidence of genotypic reversion in lymphohematopoietic stem cells","volume":"98","author":"Gregory","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2013.523_bb0110","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1159\/000069805","article-title":"Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction","volume":"98","author":"Gross","year":"2002","journal-title":"Cytogenet Genome Res"},{"key":"10.1038\/jid.2013.523_bb0115","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1038\/jid.2013.523_bb0120","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/jmg.40.10.721","article-title":"In vivo reversion to normal of inherited mutations in humans","volume":"40","author":"Hirschhorn","year":"2003","journal-title":"J Med Genet"},{"key":"10.1038\/jid.2013.523_bb0125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/ng0796-290","article-title":"Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency","volume":"13","author":"Hirschhorn","year":"1996","journal-title":"Nat Genet"},{"key":"10.1038\/jid.2013.523_bb0130","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/jid.2013.523_bb0135","doi-asserted-by":"crossref","first-page":"8797","DOI":"10.1073\/pnas.1100332108","article-title":"Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells","volume":"108","author":"Itoh","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/jid.2013.523_bb0140","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0092-8674(00)81894-2","article-title":"Revertant mosaicism in epidermolysis bullosa caused by mitotic gene conversion","volume":"88","author":"Jonkman","year":"1997","journal-title":"Cell"},{"key":"10.1038\/jid.2013.523_bb0145","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/mt.2009.144","article-title":"Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity","volume":"17","author":"Kern","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/jid.2013.523_bb0150","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1136\/jmg.2010.086751","article-title":"Molecular mechanisms of phenotypic variability in junctional epidermolysis bullosa","volume":"48","author":"Kiritsi","year":"2011","journal-title":"J Med Genet"},{"key":"10.1038\/jid.2013.523_bb0155","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nri1310","article-title":"Immune surveillance in the skin: mechanisms and clinical consequences","volume":"4","author":"Kupper","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/jid.2013.523_bb0160","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.molmed.2010.11.003","article-title":"Revertant mosaicism in skin: natural gene therapy","volume":"17","author":"Lai-Cheong","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1038\/jid.2013.523_bb0165","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1534-5807(03)00339-3","article-title":"Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosis","volume":"5","author":"Liu","year":"2003","journal-title":"Dev Cell"},{"key":"10.1038\/jid.2013.523_bb0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000484749","article-title":"Somatic mosaicism in Fanconi anemia: molecular basis and clinical significance","volume":"5","author":"Lo Ten Foe","year":"1997","journal-title":"Eur J Hum Genet"},{"key":"10.1038\/jid.2013.523_bb0175","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1182\/blood-2005-07-2638","article-title":"Natural gene therapy in monozygotic twins with Fanconi anemia","volume":"107","author":"Mankad","year":"2006","journal-title":"Blood"},{"key":"10.1038\/jid.2013.523_bb0180","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","article-title":"A more efficient method to generate integration-free human iPS cells","volume":"8","author":"Okita","year":"2011","journal-title":"Nat Methods"},{"key":"10.1038\/jid.2013.523_bb0185","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1164270","article-title":"Generation of mouse induced pluripotent stem cells without viral vectors","volume":"322","author":"Okita","year":"2008","journal-title":"Science"},{"key":"10.1038\/jid.2013.523_bb0190","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.cell.2008.07.041","article-title":"Disease-specific induced pluripotent stem cells","volume":"134","author":"Park","year":"2008","journal-title":"Cell"},{"key":"10.1038\/jid.2013.523_bb0195","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1038\/jid.2010.163","article-title":"Revertant mosaicism due to a second-site mutation in COL7A1 in a patient with recessive dystrophic epidermolysis bullosa","volume":"130","author":"Pasmooij","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.523_bb0200","first-page":"167","article-title":"Revertant mosaicism in heritable skin diseases: mechanisms of natural gene therapy","volume":"14","author":"Pasmooij","year":"2012","journal-title":"Discov Med"},{"key":"10.1038\/jid.2013.523_bb0205","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1365-2133.2010.09981.x","article-title":"Stem cell therapies for recessive dystrophic epidermolysis bullosa","volume":"163","author":"Petrova","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2013.523_bb0210","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1046\/j.1523-1747.2002.01715.x","article-title":"Partial revertant mosaicism of keratin 14 in a patient with recessive epidermolysis bullosa simplex","volume":"118","author":"Schuilenga-Hut","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.523_bb0215","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJM199611213352104","article-title":"Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells","volume":"335","author":"Stephan","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2013.523_bb0220","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nbt.1835","article-title":"Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells","volume":"29","author":"Taapken","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1038\/jid.2013.523_bb0225","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/stem.647","article-title":"Concise review: transplantation of human hematopoietic cells for extracellular matrix protein deficiency in epidermolysis bullosa","volume":"29","author":"Tolar","year":"2011","journal-title":"Stem Cells"},{"key":"10.1038\/jid.2013.523_bb0230","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1182\/blood-2008-06-161299","article-title":"Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells","volume":"113","author":"Tolar","year":"2009","journal-title":"Blood"},{"key":"10.1038\/jid.2013.523_bb0235","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1182\/blood-2010-05-287607","article-title":"Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome)","volume":"117","author":"Tolar","year":"2011","journal-title":"Blood"},{"key":"10.1038\/jid.2013.523_bb0240","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/jid.2012.278","article-title":"Keratinocytes from induced pluripotent stem cells in junctional epidermolysis bullosa","volume":"133","author":"Tolar","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.523_bb0245","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/jid.2010.346","article-title":"Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa","volume":"131","author":"Tolar","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.523_bb0250","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/jid.2010.90","article-title":"Progress in epidermolysis bullosa research: toward treatment and cure","volume":"130","author":"Uitto","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.523_bb0255","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa0910501","article-title":"Bone marrow transplantation for recessive dystrophic epidermolysis bullosa","volume":"363","author":"Wagner","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1038\/jid.2013.523_bb0260","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1038\/jid.2008.78","article-title":"Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa","volume":"128","author":"Wong","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2013.523_bb0265","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature10135","article-title":"Immunogenicity of induced pluripotent stem cells","volume":"474","author":"Zhao","year":"2011","journal-title":"Nature"},{"key":"10.1038\/jid.2013.523_bb0270","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrg2951","article-title":"Investigating monogenic and complex diseases with pluripotent stem cells","volume":"12","author":"Zhu","year":"2011","journal-title":"Nat Rev Genet"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15367968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15367968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T17:32:57Z","timestamp":1743960777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15367968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0022202X15367968"],"URL":"https:\/\/doi.org\/10.1038\/jid.2013.523","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-Specific Naturally Gene-Reverted Induced Pluripotent Stem Cells in Recessive Dystrophic Epidermolysis Bullosa","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2013.523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}